APA (7th ed.) Citation

M, S., CK, K., TP, R., LR, N., NH, H., A, S., . . . RJ, A. (2022). Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma. Pharmaceuticals (Basel, Switzerland), 15(5), . https://doi.org/10.3390/ph15050636

Chicago Style (17th ed.) Citation

M, Swetha, et al. "Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma." Pharmaceuticals (Basel, Switzerland) 15, no. 5 (2022). https://doi.org/10.3390/ph15050636.

MLA (9th ed.) Citation

M, Swetha, et al. "Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma." Pharmaceuticals (Basel, Switzerland), vol. 15, no. 5, 2022, https://doi.org/10.3390/ph15050636.